Schedule a meeting, or stop by our stand to discuss your complex biologic or bioconjugate program with our experts during CPHI Frankfurt 2025, 28-30 October.

We welcome the opportunity to schedule some time to connect on your project-specific needs and to provide you with an update on our expanded global discovery, development and manufacturing capabilities.

From antibodies (mAbs) to recombinant vaccines and bioconjugates- including ADCs, radioconjugates, and oligonucleotides, our team appreciates the chance to share how Abzena can assist in moving your program forward faster to its next milestone.

We can also provide you with an update on our expanded global capabilities and enhanced platform technology like AbZelectPRO™, our enhanced cell line development solution. AbZelectPRO™ can take you from DNA to RCB in 10 weeks with 8g/L in high-performing titers. If you are ready to achieve more from your cell line and reach IND faster, discover AbZelectPRO™.